PDEX

Pro-Dex, Inc.

Pro-Dex Inc is engaged in designing, development and manufacturing of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets.

Pro-Dex, Inc. (PDEX) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 18.6
EV / EBITDA 14.5
Rev Growth YoY 11.0%
Gross Margin 32.5%
Price Return 3M -2.2%
Price Return 12M 102.2%
Catalyst Signal 0.00
Market Cap $210.1M
TTM Revenue $79.6M
Price / Sales 2.6
ROE 26.5%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) C- (1.9) B (3.4) B- (3.0) C+ (2.6) C+ (2.8)
2026-11-07 B- (3.0) C- (1.9) B (3.4) B- (3.1) C+ (2.7) C+ (2.8)
2026-10-31 B- (3.1) C+ (2.7) B (3.4) B (3.4) C+ (2.7) B- (3.1)
2026-10-24 B- (3.1) C+ (2.7) B (3.4) B (3.4) C+ (2.6) B- (3.1)
2026-10-17 B- (3.1) C+ (2.7) B (3.4) B (3.4) C+ (2.6) B- (3.0)
Page 1 of 8
…